Works matching IS 21938210 AND DT 2020 AND VI 10 AND IP 3
Results: 17
Correction to: Comparative Study to Evaluate Tolerability of Topical 5% Minoxidil Novel Formulation and Alcohol-Based Conventional Solutions in Treatment of Androgenetic Alopecia in Indian Men: Randomized Double-Blind Study.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
A Preclinical Investigation into the Effects of Aging on Dermal Hyaluronan Properties and Reconstitution Following Recombinant Human Hyaluronidase PH20 Administration.
- Published in:
- Dermatology & Therapy, 2020, v. 10, n. 3, p. 503, doi. 10.1007/s13555-020-00380-0
- By:
- Publication type:
- Article
Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study.
- Published in:
- Dermatology & Therapy, 2020, v. 10, n. 3, p. 515, doi. 10.1007/s13555-020-00379-7
- By:
- Publication type:
- Article
Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma.
- Published in:
- Dermatology & Therapy, 2020, v. 10, n. 3, p. 401, doi. 10.1007/s13555-020-00378-8
- By:
- Publication type:
- Article
Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Evaluation of Accountability Measurement Tool in Patients with Psoriasis: A Validation Study.
- Published in:
- Dermatology & Therapy, 2020, v. 10, n. 3, p. 495, doi. 10.1007/s13555-020-00376-w
- By:
- Publication type:
- Article
Comparative Study to Evaluate Tolerability of Topical 5% Minoxidil Novel Formulation and Alcohol-Based Conventional Solutions in Treatment of Androgenetic Alopecia in Indian Men: Randomized Double-Blind Study.
- Published in:
- Dermatology & Therapy, 2020, v. 10, n. 3, p. 469, doi. 10.1007/s13555-020-00374-y
- By:
- Publication type:
- Article
Machine Learning in Dermatology: Current Applications, Opportunities, and Limitations.
- Published in:
- Dermatology & Therapy, 2020, v. 10, n. 3, p. 365, doi. 10.1007/s13555-020-00372-0
- By:
- Publication type:
- Article
Patient Education Programs in Pediatric Atopic Dermatitis: A Systematic Review of Randomized Controlled Trials and Meta-Analysis.
- Published in:
- Dermatology & Therapy, 2020, v. 10, n. 3, p. 449, doi. 10.1007/s13555-020-00365-z
- By:
- Publication type:
- Article
Psoriasis Vulgaris Successfully Treated with Goeckerman Treatment at Home: A Patient and Physician's Experience.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence.
- Published in:
- Dermatology & Therapy, 2020, v. 10, n. 3, p. 351, doi. 10.1007/s13555-020-00373-z
- By:
- Publication type:
- Article
Low-Dose Vismodegib as Maintenance Therapy After Locally Advanced Basal Cell Carcinoma Complete Remission: High Efficacy with Minimal Toxicity.
- Published in:
- Dermatology & Therapy, 2020, v. 10, n. 3, p. 465, doi. 10.1007/s13555-020-00371-1
- By:
- Publication type:
- Article
Correction to: Review of Comorbidities of Hidradenitis Suppurativa: Implications for Daily Clinical Practice.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Cyclosporine With and Without Systemic Corticosteroids in Treatment of Alopecia Areata: A Systematic Review.
- Published in:
- Dermatology & Therapy, 2020, v. 10, n. 3, p. 387, doi. 10.1007/s13555-020-00370-2
- By:
- Publication type:
- Article
Efficacy of Postbiotics in a PRP-Like Cosmetic Product for the Treatment of Alopecia Area Celsi: A Randomized Double-Blinded Parallel-Group Study.
- Published in:
- Dermatology & Therapy, 2020, v. 10, n. 3, p. 483, doi. 10.1007/s13555-020-00369-9
- By:
- Publication type:
- Article
Acceptance of Illness, Satisfaction with Life, Sense of Stigmatization, and Quality of Life among People with Psoriasis: A Cross-Sectional Study.
- Published in:
- Dermatology & Therapy, 2020, v. 10, n. 3, p. 413, doi. 10.1007/s13555-020-00368-w
- By:
- Publication type:
- Article
Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials.
- Published in:
- Dermatology & Therapy, 2020, v. 10, n. 3, p. 431, doi. 10.1007/s13555-020-00367-x
- By:
- Publication type:
- Article